- Home
- VTRS vs COKE Comparison
VTRS vs COKE Comparison
Compare VTRS & COKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTRS
- COKE
- Stock Information
- Founded
- VTRS 1961
- COKE 1902
- Country
- VTRS United States
- COKE United States
- Employees
- VTRS N/A
- COKE N/A
- Industry
- VTRS Medicinal Chemicals and Botanical Products
- COKE Beverages (Production/Distribution)
- Sector
- VTRS Health Care
- COKE Consumer Staples
- Exchange
- VTRS Nasdaq
- COKE Nasdaq
- Market Cap
- VTRS 12.2B
- COKE 10.0B
- IPO Year
- VTRS N/A
- COKE N/A
- Fundamental
- Price
- VTRS $10.64
- COKE $159.73
- Analyst Decision
- VTRS Hold
- COKE
- Analyst Count
- VTRS 6
- COKE 0
- Target Price
- VTRS $11.17
- COKE N/A
- AVG Volume (30 Days)
- VTRS 9.2M
- COKE 480.0K
- Earning Date
- VTRS 11-06-2025
- COKE 10-29-2025
- Dividend Yield
- VTRS 4.50%
- COKE 0.63%
- EPS Growth
- VTRS N/A
- COKE 22.14
- EPS
- VTRS N/A
- COKE 7.03
- Revenue
- VTRS $14,124,400,000.00
- COKE $7,070,308,000.00
- Revenue This Year
- VTRS N/A
- COKE N/A
- Revenue Next Year
- VTRS $1.61
- COKE N/A
- P/E Ratio
- VTRS N/A
- COKE $22.70
- Revenue Growth
- VTRS N/A
- COKE 4.22
- 52 Week Low
- VTRS $6.85
- COKE $105.21
- 52 Week High
- VTRS $13.55
- COKE $162.43
- Technical
- Relative Strength Index (RSI)
- VTRS 55.17
- COKE 82.78
- Support Level
- VTRS $9.92
- COKE $127.09
- Resistance Level
- VTRS $11.28
- COKE $162.43
- Average True Range (ATR)
- VTRS 0.35
- COKE 4.96
- MACD
- VTRS 0.03
- COKE 2.66
- Stochastic Oscillator
- VTRS 54.41
- COKE 91.53
About VTRS Viatris Inc.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
About COKE Coca-Cola Consolidated Inc.
Coca-Cola Consolidated Inc distributes, markets and manufactures nonalcoholic beverages. It offer a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages and the Company's principal sparkling beverage is Coca Cola. Still beverages include energy products and noncarbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices and sports drinks. The Company has three operating segments: Nonalcoholic Beverages, All Other and Eliminations. key revenue is generated from Nonalcoholic Beverages.